Facilitating Automated Data Analytics Through Structured Head and Neck Oncology Tumor Board Documentation.

Autor: Yalamanchi P; Pratyusha Yalamanchi, MD, MBA, and Keith A. Casper, MD, Department of Otolaryngology-Head and Neck Surgery, Michigan Medicine, Ann Arbor, MI; Joseph Evans, MD, and Michelle Mierzwa, MD, Department of Radiation Oncology, University of Michigan, Ann Arbor, MI; Robert J. Morrison, MD, and Mark E. Prince, MD, Department of Otolaryngology-Head and Neck Surgery, Michigan Medicine, Ann Arbor, MI; and Charles S. Mayo, PhD, Department of Radiation Oncology, University of Michigan, Ann Arbor, MI., Casper KA; Pratyusha Yalamanchi, MD, MBA, and Keith A. Casper, MD, Department of Otolaryngology-Head and Neck Surgery, Michigan Medicine, Ann Arbor, MI; Joseph Evans, MD, and Michelle Mierzwa, MD, Department of Radiation Oncology, University of Michigan, Ann Arbor, MI; Robert J. Morrison, MD, and Mark E. Prince, MD, Department of Otolaryngology-Head and Neck Surgery, Michigan Medicine, Ann Arbor, MI; and Charles S. Mayo, PhD, Department of Radiation Oncology, University of Michigan, Ann Arbor, MI., Evans J; Pratyusha Yalamanchi, MD, MBA, and Keith A. Casper, MD, Department of Otolaryngology-Head and Neck Surgery, Michigan Medicine, Ann Arbor, MI; Joseph Evans, MD, and Michelle Mierzwa, MD, Department of Radiation Oncology, University of Michigan, Ann Arbor, MI; Robert J. Morrison, MD, and Mark E. Prince, MD, Department of Otolaryngology-Head and Neck Surgery, Michigan Medicine, Ann Arbor, MI; and Charles S. Mayo, PhD, Department of Radiation Oncology, University of Michigan, Ann Arbor, MI., Mierzwa M; Pratyusha Yalamanchi, MD, MBA, and Keith A. Casper, MD, Department of Otolaryngology-Head and Neck Surgery, Michigan Medicine, Ann Arbor, MI; Joseph Evans, MD, and Michelle Mierzwa, MD, Department of Radiation Oncology, University of Michigan, Ann Arbor, MI; Robert J. Morrison, MD, and Mark E. Prince, MD, Department of Otolaryngology-Head and Neck Surgery, Michigan Medicine, Ann Arbor, MI; and Charles S. Mayo, PhD, Department of Radiation Oncology, University of Michigan, Ann Arbor, MI., Morrison RJ; Pratyusha Yalamanchi, MD, MBA, and Keith A. Casper, MD, Department of Otolaryngology-Head and Neck Surgery, Michigan Medicine, Ann Arbor, MI; Joseph Evans, MD, and Michelle Mierzwa, MD, Department of Radiation Oncology, University of Michigan, Ann Arbor, MI; Robert J. Morrison, MD, and Mark E. Prince, MD, Department of Otolaryngology-Head and Neck Surgery, Michigan Medicine, Ann Arbor, MI; and Charles S. Mayo, PhD, Department of Radiation Oncology, University of Michigan, Ann Arbor, MI., Prince ME; Pratyusha Yalamanchi, MD, MBA, and Keith A. Casper, MD, Department of Otolaryngology-Head and Neck Surgery, Michigan Medicine, Ann Arbor, MI; Joseph Evans, MD, and Michelle Mierzwa, MD, Department of Radiation Oncology, University of Michigan, Ann Arbor, MI; Robert J. Morrison, MD, and Mark E. Prince, MD, Department of Otolaryngology-Head and Neck Surgery, Michigan Medicine, Ann Arbor, MI; and Charles S. Mayo, PhD, Department of Radiation Oncology, University of Michigan, Ann Arbor, MI., Mayo CS; Pratyusha Yalamanchi, MD, MBA, and Keith A. Casper, MD, Department of Otolaryngology-Head and Neck Surgery, Michigan Medicine, Ann Arbor, MI; Joseph Evans, MD, and Michelle Mierzwa, MD, Department of Radiation Oncology, University of Michigan, Ann Arbor, MI; Robert J. Morrison, MD, and Mark E. Prince, MD, Department of Otolaryngology-Head and Neck Surgery, Michigan Medicine, Ann Arbor, MI; and Charles S. Mayo, PhD, Department of Radiation Oncology, University of Michigan, Ann Arbor, MI.
Jazyk: angličtina
Zdroj: JCO clinical cancer informatics [JCO Clin Cancer Inform] 2022 Feb; Vol. 6, pp. e2100168.
DOI: 10.1200/CCI.21.00168
Abstrakt: Competing Interests: Michelle MierzwaResearch Funding: Debiopharm Group Mark E. PrincePatents, Royalties, Other Intellectual Property: Receive royalties for several head and neck cancer cell lines managed by EMD Millipore Corp, US Patent US 7,723,112 B2. Compositions and Methods for Diagnosing and Treating Cancer Patents licensed to OncoMed. This is a method for sorting cancer cells to isolate cancer stem cells. Charles S. MayoResearch Funding: Varian Medical SystemsNo other potential conflicts of interest were reported.
Databáze: MEDLINE